Image 1_Increasing plasma ketamine concentrations decrease the minimum alveolar concentration of isoflurane in rabbits.jpeg by Linda S. Barter (21466916)

Additional file 6 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 9 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 8 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Risk of acquiring SARS-CoV-2 infection in the household (children vs. adults). by Jesús Poch-Páez (21807825)

Subjects:

Correlation and median comparison. ACE2 and TMPRSS2 expression. by Jesús Poch-Páez (21807825)

Subjects:

Most common symptoms and frequency of appearance among IgG-positive patients. by Jesús Poch-Páez (21807825)

Subjects:

Characteristics of patients with <i>ACE2ACE2</i> and <i>TMPRSS2</i> expression. by Jesús Poch-Páez (21807825)

Subjects:

Correlation between age and antibody indexes in both children and adults. by Jesús Poch-Páez (21807825)

Subjects:

The interaction of ACE2 and TMPRSS2 with SARS-CoV-2. by Jesús Poch-Páez (21807825)

Subjects:

Supplementary file 1_Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future.docx by Emmama Jamil (22005635)

RipU^K60 decreases microtubule abundance at 48 hours post infiltration. by Rachel Hiles (20477573)

“…(B) Heterologous expression of RipU^K60 significantly decreased microtubule number compared to controls at 48 hpi in <i>N</i>. …”

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Susceptibility of thalassemic and healthy RBCs to hemolysis (A) and the anti-hemolytic activity of 6-shogaol-rich ginger extract (0–200 µg/mL) compared to ascorbic acid (AA; 100 µg... by Hataichanok Chuljerm (19144293)

Evolution of the four pre-stimuli psychological parameters (A: Valence, B: Arousal, C: Tension, D: Energy). by Felix Alexandre Schoeller (20988295)